Tambocor

Tambocor

flecainide

Manufacturer:

iNova

Distributor:

Metro Drug
Concise Prescribing Info
Contents
Flecainide acetate
Indications/Uses
Treatment of paroxysmal supraventricular tachycardias, paroxysmal atrial fibrillation/flutter, symptomatic sustained ventricular tachycardia, premature ventricular contractions &/or nonsustained ventricular tachycardia causing disabling symptoms in patient resistant to or intolerant of other therapy.
Dosage/Direction for Use
1 tab bid. Max: 400 mg daily. After 3-5 days adjust dosage to the lowest level to maintain control of the arrhythmia.
Administration
May be taken with or without food.
Contraindications
Cardiac failure, patient w/ history of MI who has either asymptomatic ventricular ectopics or asymptomatic nonsustained ventricular tachycardia. Sinus nodal dysfunction, atrial conduction defects, 2nd-degree or greater AV block, bundle branch block or distal block unless pacing rescue available.
Special Precautions
Prior electrolyte disturbances. Renal or significant hepatic impairment. Patients w/ permanent pacemakers or temporary pacing electrodes; predisposition to cardiac failure. Concomitant use w/ other antiarrhythmics. Pregnancy & lactation. Childn.
Adverse Reactions
Giddiness, dizziness & lightheadedness. Visual disturbances eg double vision & blurring of vision.
Drug Interactions
Digoxin, β-blockers & other cardiac depressants; antiarrhythmics, enzyme inducers, amiodarone, other Na channel blockers, cimetidine.
MIMS Class
ATC Classification
C01BC04 - flecainide ; Belongs to class Ic antiarrhythmics.
Presentation/Packing
Form
Tambocor tab 100 mg
Packing/Price
90's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in